You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Conversion of TNBC to Luminal BC

Showing 1 - 25 of 1,923
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer, Triple Negative Breast Cancer Trial in Gothenburg (Imatinib 400 MG Oral Tablet)

Not yet recruiting
  • Breast Cancer
  • Triple Negative Breast Cancer
  • Imatinib 400 MG Oral Tablet
  • Gothenburg, Sweden
    Barbro Linderholm
Feb 1, 2023

Triple Negative Breast Cancer Trial in Spain (Carboplatin, Gemcitabine, Nadunolimab)

Recruiting
  • Triple Negative Breast Cancer
  • Málaga, Andalucía, Spain
  • +11 more
Feb 15, 2022

Epidemiology of TNBC in Asyut Clinical Oncology Department

Not yet recruiting
  • Breast Cancer
    • (no location specified)
    Oct 15, 2022

    Triple-Negative Breast Cancer Trial in Shanghai (Trastuzumab Deruxtecan)

    Not yet recruiting
    • Triple-Negative Breast Cancer
    • Trastuzumab Deruxtecan
    • Shanghai, Shanghai, China
      Breast cancer institute of Fudan University Cancer Hospital
    Jul 12, 2023

    Breast Cancer Trial in Amsterdam (Nivolumab, Ipilimumab)

    Recruiting
    • Breast Cancer
    • Amsterdam, Netherlands
      NKI-AVL
    Mar 31, 2022

    Breast Cancer Trial in Angers, Saint-Herblain (Biopsy, Blood samples, Questionnaires)

    Not yet recruiting
    • Breast Cancer
    • Biopsy
    • +2 more
    • Angers, France
    • +1 more
    Jul 31, 2023

    Metastatic Breast Cancer Trial in United States (Enzalutamide, Mifepristone, TPC)

    Recruiting
    • Metastatic Breast Cancer
    • Birmingham, Alabama
    • +5 more
    Oct 19, 2023

    Breast Cancer, Oligometastasis, Metastatic Breast Cancer Trial in Tokyo (Systemic therapy for 12 weeks after primary

    Recruiting
    • Breast Cancer
    • +2 more
    • Systemic therapy for 12 weeks after primary registration
    • +3 more
    • Tokyo, Japan
      Tokyo Medical and Dental Univetsity
    Nov 15, 2023

    Breast Cancer, Radiotherapy Trial in Bologna (SBRT anticipated boost)

    Recruiting
    • Breast Cancer
    • Radiotherapy
    • SBRT anticipated boost
    • Bologna, Italy
      IRCCS Azienda Ospedaliero-Universitaria di Bologna
    Jan 9, 2023

    Triple Negative Breast Cancer, Metastatic Breast Cancer, Mutation Trial in Shanghai (Everolimus, Investigator's Choice of

    Not yet recruiting
    • Triple Negative Breast Cancer
    • +2 more
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Jul 25, 2023

    Hepatocellular Carcinoma, Pancreatic Ductal Adenocarcinoma, Biliary Tract Cancers Trial (ABBV-400)

    Not yet recruiting
    • Hepatocellular Carcinoma
    • +6 more
    • (no location specified)
    Oct 10, 2023

    Breast Cancer Trial in Zhengzhou (Capecitabine+endocrine therapy, Placebo+endocrine therapy)

    Recruiting
    • Breast Cancer
    • Capecitabine+endocrine therapy
    • Placebo+endocrine therapy
    • Zhengzhou, Henan, China
      Henan cancer hospital
    Nov 19, 2022

    Risk Reduction Behavior, Breast Cancer, Health Behavior Trial in Ile-Ife, Ibadan, Lagos (Individualized breast cancer risk

    Completed
    • Risk Reduction Behavior
    • +4 more
    • Individualized breast cancer risk assessment
    • Individualized breast cancer risk counselling
    • Ile-Ife, Osun, Nigeria
    • +3 more
    Apr 17, 2023

    Locoregional Recurrence of Breast Cancer

    Not yet recruiting
    • Locoregional Recurrence
      • (no location specified)
      Aug 4, 2023

      HER2-low in Unresectable and/or Metastatic Breast Cancer

      Not yet recruiting
      • Breast Neoplasms, Breast Cancer, Breast Carcinoma, Genes, HER-2, Genes, HER2
        • (no location specified)
        Nov 6, 2023

        Metastatic Triple-negative Breast Cancer Trial in Italy (Tissue Immune Profile)

        Recruiting
        • Metastatic Triple-negative Breast Cancer
        • Tissue Immune Profile
        • Prato, FI, Italy
        • +6 more
        Apr 14, 2023

        Cervical Ripening, Labor, Induced Trial (Balloon Catheter for cervical ripening)

        Not yet recruiting
        • Cervical Ripening
        • Labor, Induced
        • Balloon Catheter for cervical ripening
        • (no location specified)
        May 8, 2023

        Immunotherapy-related CRP Kinetics in Early and Metastatic

        Recruiting
        • TNBC - Triple-Negative Breast Cancer
          • Tuebingen, Germany
            Department of Women's Health
          Jun 13, 2023

          Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Trial

          Not yet recruiting
          • Anatomic Stage I Breast Cancer AJCC v8
          • +2 more
          • Behavioral Dietary Intervention
          • +13 more
          • Seattle, Washington
            Fred Hutch/University of Washington Cancer Consortium
          Jul 5, 2023

          Patterns Among PIK3CA Mutation in Advanced Breast Cancer

          Completed
          • Breast Cancer
            • East Hanover, New Jersey
              Novartis
            Aug 1, 2023

            Breast Tumors Trial in Roma, Rome (Single-cell RNA sequencing (scRNAseq), whole-exome sequencing (WES))

            Recruiting
            • Breast Neoplasms
            • Single-cell RNA sequencing (scRNAseq), whole-exome sequencing (WES)
            • Roma, Italy
            • +1 more
            Mar 29, 2023

            "The Evaluation Tool For Myofascial Adhesions In Patients After

            Not yet recruiting
            • Breast Cancer
            • +2 more
            • MAP-BC (Myofascial Adhesions in Patients after Breast Cancer) Evaluation Tool
            • Patient And Observer Scar Assessment Scale ( Observer Subscale)
            • İstanbul, Kadıköy, Turkey
              Sultan 2. Abdulhamid Han Training and Research Hospital
            Jun 19, 2023

            Triple Negative Breast Cancer, TNBC - Triple-Negative Breast Cancer, NSCLC Trial in United States (LYL797)

            Recruiting
            • Triple Negative Breast Cancer
            • +14 more
            • LYL797
            • Scottsdale, Arizona
            • +10 more
            Jan 30, 2023

            TNBC - Triple-Negative Breast Cancer Trial (Alkaline Glucosodiene Molecules)

            Not yet recruiting
            • TNBC - Triple-Negative Breast Cancer
            • Alkaline Glucosodiene Molecules
            • (no location specified)
            Jul 14, 2023

            Triple-Negative Breast Cancer Trial in Shanghai (VEGFR, nab-paclitaxel, Eribulin Mesylate/Vinorelbine/Capecitabine/Carboplatin)

            Recruiting
            • Triple-Negative Breast Cancer
            • Shanghai, Shanghai, China
              Breast cancer institute of Fudan University Cancer Hospital
            Mar 28, 2023